Method for treating pancreatic cancer
US12023335B2 · kind B2 · utility
0Cited by
23References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 2019 |
| Grant date | Jul 2, 2024 |
| Priority date | — |
| Expiry date | Aug 17, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating pancreatic cancer in a subject in need thereof comprising, administering to the subject an effective amount of a tubulin polymerization inhibitor compound is described herein. More particularly, a method for treating pancreatic ductal adenocarcinoma in a subject in need thereof comprising, administering to the subject an effective amount of a substituted reverse pyrimidine tubulin polymerization inhibitor compound alone or in combination with other chemo-therapeutic agents is described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.